A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer’s Disease Subjects: Results of a Single-Arm, Pilot Trial

Manuscript Number: 

17-0077R2

Author(s): 
Rebecca Bothwell, Jeffrey M. Burns, Richard L. Jackson, Scott Koppel, Jonathan D. Mahnken, Russell H. Swerdlow, Paul Welch, Heather M. Wilkins

Disclosures

Rebecca Bothwell

  • Grants
    • Agency: 
      Ausio Pharmaceuticals, LLC
      Dates: 
      2014-present

Jeffrey M. Burns

  • Grants
    • Agency: 
      Ausio Pharamceuticals, LLC
      Dates: 
      2014-present

Richard L. Jackson

  • Consulting Fees:
    I receive $50,000/year as a consultant to Ausio Pharmaceuticals
    Equity:
    I own approximately 1% of the equity in Ausio Pharmaceuticals.

Scott Koppel

  • Nothing to Disclose

Jonathan D. Mahnken

  • Grants
    • Agency: 
      Ausio Pharmaceuticals, LLC
      Dates: 
      2014-present

Russell H. Swerdlow

  • Grants
    • Agency: 
      Ausio Pharmaceuticals, LLC
      Dates: 
      2014-present

Paul Welch

  • Nothing to Disclose

Heather M. Wilkins

  • Nothing to Disclose